Elevation Oncology Reports First Quarter 2022 Financial Results and Highlights Recent Company ProgressPRNewsWire • 05/05/22
Elevation Oncology Announces Initial Data from Phase 2 CRESTONE Study of Seribantumab Selected for Oral Presentation at ASCO 2022PRNewsWire • 04/27/22
Elevation Oncology Highlights 2021 Achievements and Outlines Expected 2022 MilestonesPRNewsWire • 01/10/22
Elevation Oncology to Present at the H.C. Wainwright BIOCONNECT Virtual ConferencePRNewsWire • 01/06/22
Elevation Oncology to Present at the 40th Annual J.P. Morgan Healthcare ConferencePRNewsWire • 01/05/22
Elevation Oncology to Present at the Piper Sandler 33rd Annual Virtual Healthcare ConferencePRNewsWire • 11/18/21
Elevation Oncology Announces the Promotion of Valerie Malyvanh Jansen, M.D., Ph.D., to Chief Medical OfficerPRNewsWire • 10/20/21
Elevation Oncology's Seribantumab Included as Part of a Case Series Presentation at the Australasian Gastro-Intestinal Trials Group 2021 Annual Scientific MeetingPRNewsWire • 10/14/21
Elevation Oncology to Present at the H.C. Wainwright 23rd Annual Global Investment ConferencePRNewsWire • 09/07/21
Elevation Oncology to Present at the 12th Annual Wedbush PacGrow Healthcare ConferencePRNewsWire • 08/04/21